Urania Therapeutics
FranceEntry
2019
Hold
7yr
Status
Active
Who owns Urania Therapeutics?
Urania Therapeutics is currently owned by AdBio Partners through AFB Seed-Fund (2017 vintage), since 2019. Across its history, Urania Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2019 · present
AdBio PartnersActive
2019 · present(7yr) · AFB Seed-Fund · 2017 · VC
Capital Grand EstActive
2020 · present(6yr) · Cap Innov'Est 1 · 2014 · VC
More from AFB Seed-Fund
Other portfolio companies in the same fund.
Spain
BelgiumMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Urania Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Urania Therapeutics?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Urania Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue